Erica Ollmann Saphire, Ph.D., is a Professor of the La Jolla Institute for Immunology. Her research explains, at the molecular level, how and why viruses are pathogenic and provides the roadmap for medical defense. Her team has solved the structures of the Ebola, Sudan, Marburg, Bundibugyo and Lassa virus glycoproteins, explained how they remodel these structures as they drive themselves into cells, how their proteins suppress immune function and where human antibodies can defeat these viruses.
Prof. Saphire is currently leading a Bill & Melinda Gates Foundation-supported consortium to evaluate antibody therapeutics against SARS-CoV-2 to prevent and treat COVID-19. This consortium, CoVIC (covic.lji.org) analyzes the world’s leading therapeutic candidates side-by-side, and uses LJI’s powerful pair of Titan Krios microscopes for high-resolution analysis of the antibody interactions.
She was also the galvanizing force behind the Viral Hemorrhagic Fever Immunotherapeutic Consortium and is directing this NIAID-supported organization. This consortium, Center of Excellence in Translational Research, unites 44 previously competing academic, industrial and government labs across five continents to understand and provide antibody therapeutics against Ebola, Marburg, Lassa and other viruses. A recent discovery from Instructor Kathryn Hastie revealed why neutralizing antibodies had been so difficult to elicit against Lassa virus, and provided not only the templates for the needed vaccine, but the molecule itself: a Lassa surface glycoprotein engineered to remain in the right conformation to inspire the needed antibody response. This molecule is the basis for international vaccine efforts against Lassa. Other work in their lab reveals how these and other viruses replicate and assemble using a variety of biophysical, biochemical, and immunological methods.
Dr. Saphire’s work has been recognized at the White House with the Presidential Early Career Award in Science and Engineering, with young investigator awards from the International Congress of Antiviral Research, the American Society for Microbiology, and the MRC Centre for Virus Research in the United Kingdom. She has been awarded a Fulbright Global Scholar fellowship from the United States Department of State and a Mercator Fellowship from Deutsche Forschungsgemeinschaft, to develop international collaborations using cryoelectron microscopy to further global health.
Very well deserved honour for the CVR Chief twitter.com/UofGMVLS/statu…
RT @HumanVacProject: Save the date for our next Global #COVID Lab meeting with #immunology experts @Dani6020 and @SetteLab of @ljiresearch.…
A wise leader knows when to follow. Clone Wars 2:16
RT @BriggsGroup: We are looking for a lab manager and a TA to join us in our future home @MPI_Biochem. Viruses, Cells, Electron Microscopes…
RT @vsv512: Post-doctoral position(s) available in my group to work on emerging virus infections. We are studying the molecular mechanisms…
RT @CVRinfo: Today we’re remembering our colleague Prof Richard Elliot who passed away 6 years ago. Richard was an expert in emerging vir…
Some of the best structural biologists went into the field because of the beauty, artistry & symmetry of biological molecules: how these stunning forms are deployed in their intricate functions. Dr. Zyla + others in the lab capture life at both macroscopic and microscopic levels. twitter.com/ljiresearch/st…
RT @DawidZyla: Not entirely scientific contribution this time 😉 twitter.com/ljiresearch/st…
RT @ljiresearch: LJI Postdoc Timothy Baffi receives @AmericanCancer award to study acute myeloid #leukemia bit.ly/3wWOeug "Stud…
RT @SetteLab: We are excited to get to work on this exciting project making cancer epitope data broadly available to the community.
RT @ljiresearch: Four key points from this week's meta-analysis of #SARSCoV2 human #Tcell epitopes: 1. The researchers evaluated all 25 kn…
RT @iedb_: The IEDB is very proud to have been used in the latest metanalysis from @ljiresearch, continuing to further our understanding of…
From the lab
Erica Ollman Saphire brings together scientific competitors to find new antibody therapeutics for COVID-19.
Dr. Saphire will become La Jolla Institute’s fifth president when she formally begins her term on September 1, 2021
Awards & Honors
- Fulbright Global Scholar Award, 2019-2020
- Mercator Fellowship, DFG, Philipps Universitaet Marburg, 2018
- Eli Lilly and Company-Elanco Research Award, American Society for Microbiology, 2016
- Finalist, Classy Award for the Most Innovative Nonprofits and Social Enterprises of 2016 for VIC, 2016
- "Cool Woman", Girl Scouts San Diego, 2016
- William Prusoff Young Investigator Award, Int. Society for Antiviral Research, 2015
- Young Investigator Award, ASBMB, 2015
- Fellow, American Association for the Advancement of Science, 2015
- Fellow, American Academy of Microbiology, 2014
- Presidential Early Career Award in Science and Engineering, 2009
- Investigator in the Pathogenesis of Infectious Disease, Burroughs Wellcome Fund, 2009-2015
- ICAAC Young Investigator Award, American Society for Microbiology, 2006
- Career Award in the Biomedical Sciences, Burroughs Wellcome Fund, 2003-2008
- New Initiatives Award in Global Infectious Disease, Ellison Medical Foundation, 2003
- Surhain Sidhu Award, 2003